R&D spending news from FierceBioResearcher
News
Study outlines billions in potential R&D savings
Better standardization of data collection and analysis could save between 25 percent and 48 percent of R&D expenses for each new drug approved by the FDA, according to a new study sponsored by Read more...
Get more R&D spending coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight